Literature DB >> 12040735

Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry.

Gudrun Schmaus1, Rudolf Schierl, Sabine Funck.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12040735     DOI: 10.1093/ajhp/59.10.956

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  14 in total

1.  Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.

Authors:  Jack R Pretty; Thomas H Connor; Ivan Spasojevic; Kristine S Kurtz; Jeffrey L McLaurin; Clayton B'Hymer; D Gayle Debord
Journal:  J Oncol Pharm Pract       Date:  2010-12-23       Impact factor: 1.809

2.  Evaluation of working practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings.

Authors:  Bettina Kopp; Rudolf Schierl; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2012-02-05       Impact factor: 3.015

3.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

Review 4.  Environmental monitoring by surface sampling for cytotoxics: a review.

Authors:  Petit Marie; Curti Christophe; Roche Manon; Montana Marc; Bornet Charleric; Vanelle Patrice
Journal:  Environ Monit Assess       Date:  2017-01-06       Impact factor: 2.513

5.  Pilot Evaluation of Dermal Contamination by Antineoplastic Drugs among Hospital Pharmacy Personnel.

Authors:  Chun-Yip Hon; George Astrakianakis; Quinn Danyluk; Winnie Chu
Journal:  Can J Hosp Pharm       Date:  2011-09

6.  Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals.

Authors:  Susana Viegas; Mário Pádua; Ana Costa Veiga; Elisabete Carolino; Mário Gomes
Journal:  Environ Monit Assess       Date:  2014-08-06       Impact factor: 2.513

7.  Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients.

Authors:  Maria Hedmer; Peter Höglund; Eva Cavallin-Ståhl; Maria Albin; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-06-20       Impact factor: 3.015

8.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

9.  Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.

Authors:  M Hedmer; H Tinnerberg; A Axmon; B A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2007-12-08       Impact factor: 3.015

10.  Occupational Exposure to Antineoplastic Drugs: Identification of Job Categories Potentially Exposed throughout the Hospital Medication System.

Authors:  Chun-Yip Hon; Kay Teschke; Prescillia Chua; Scott Venners; Lynne Nakashima
Journal:  Saf Health Work       Date:  2011-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.